KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Total Non-Current Liabilities (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Total Non-Current Liabilities for 8 consecutive years, with $106.2 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 40.83% to $106.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $106.2 million through Dec 2025, up 40.83% year-over-year, with the annual reading at $106.2 million for FY2025, 40.83% up from the prior year.
  • Total Non-Current Liabilities hit $106.2 million in Q4 2025 for Castle Biosciences, up from $94.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $106.2 million in Q4 2025 to a low of $18.7 million in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $52.3 million across 5 years, with a median of $47.1 million in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 152.07% in 2022 and later fell 11.47% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $32.5 million in 2021, then surged by 47.76% to $48.1 million in 2022, then increased by 29.02% to $62.0 million in 2023, then grew by 21.52% to $75.4 million in 2024, then skyrocketed by 40.83% to $106.2 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for CSTL at $106.2 million in Q4 2025, $94.2 million in Q3 2025, and $87.9 million in Q2 2025.